Registries are powerful tools for conducting observational studies of disease with impact on public health surveillance, research, and intervention, and inform and engage policymakers. Frank Jessen, one of our founding Board members, shared at the EADC (European Alzheimer's Disease Consortium) annual meeting how InRAD may impact clinical management, foster large-scale collaborations, and enable global studies. Join us in accelerating Alzheimer's research! https://lnkd.in/gGDTvs6i #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry
We were delighted to introduce InRAD, an international, practice-based registry for Alzheimer's Disease and other dementias at the EADC (European Alzheimer's Disease Consortium) annual meeting yesterday. One of our founding Board members, Frank Jessen, explained how InRAD can help address pressing questions about the clinical management of Alzheimer's disease, enable large study collaborations with a common minimum data set and facilitate a wide range of sub-studies on a global scale. Click here to find out more about InRAD and join our effort to accelerate progress in Alzheimer's practice-based research: https://lnkd.in/gGDTvs6i #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry